Tong-Chuan He to CD8-Positive T-Lymphocytes
This is a "connection" page, showing publications Tong-Chuan He has written about CD8-Positive T-Lymphocytes.
Connection Strength
0.189
-
Targeting the lipid kinase PIKfyve upregulates surface expression of MHC class I to augment cancer immunotherapy. Proc Natl Acad Sci U S A. 2023 Dec 05; 120(49):e2314416120.
Score: 0.170
-
LIGHT delivery to tumors by mesenchymal stem cells mobilizes an effective antitumor immune response. Cancer Res. 2012 Jun 15; 72(12):2980-9.
Score: 0.019